Bowei Ni

463 total citations
16 papers, 362 citations indexed

About

Bowei Ni is a scholar working on Rheumatology, Molecular Biology and Pharmacology. According to data from OpenAlex, Bowei Ni has authored 16 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 10 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Bowei Ni's work include Osteoarthritis Treatment and Mechanisms (13 papers), Inflammatory mediators and NSAID effects (6 papers) and Natural product bioactivities and synthesis (6 papers). Bowei Ni is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (13 papers), Inflammatory mediators and NSAID effects (6 papers) and Natural product bioactivities and synthesis (6 papers). Bowei Ni collaborates with scholars based in China, United Kingdom and United States. Bowei Ni's co-authors include Xiaojian Huang, Hongbo You, Xiangyu Chu, Xi Yang, Rui Zhang, Zekai Mao, Rui Zhang, Rui Zhang, Ying-Guang Wang and Hao Cheng and has published in prestigious journals such as European Journal of Pharmacology, Frontiers in Pharmacology and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Bowei Ni

15 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bowei Ni China 12 192 135 70 52 46 16 362
Songjiang Yin China 11 301 1.6× 171 1.3× 67 1.0× 62 1.2× 62 1.3× 21 518
Zekai Mao China 12 186 1.0× 127 0.9× 70 1.0× 47 0.9× 40 0.9× 18 382
Pratap Devarapalli Australia 5 157 0.8× 102 0.8× 82 1.2× 23 0.4× 31 0.7× 11 293
Dengying Wu China 10 309 1.6× 134 1.0× 92 1.3× 133 2.6× 25 0.5× 14 489
Jun Pan China 13 273 1.4× 120 0.9× 81 1.2× 123 2.4× 41 0.9× 24 525
Yumei Ding China 16 144 0.8× 96 0.7× 30 0.4× 57 1.1× 25 0.5× 36 709
Ju‐Ryoung Kim South Korea 11 306 1.6× 110 0.8× 63 0.9× 39 0.8× 40 0.9× 19 550
Xiangyi Chen China 11 177 0.9× 49 0.4× 88 1.3× 41 0.8× 22 0.5× 24 418

Countries citing papers authored by Bowei Ni

Since Specialization
Citations

This map shows the geographic impact of Bowei Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bowei Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bowei Ni more than expected).

Fields of papers citing papers by Bowei Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bowei Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bowei Ni. The network helps show where Bowei Ni may publish in the future.

Co-authorship network of co-authors of Bowei Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Bowei Ni. A scholar is included among the top collaborators of Bowei Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bowei Ni. Bowei Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Xu, Xiaojie, Dong Wang, Bowei Ni, et al.. (2025). Inhibiting the REV-ERBα expression protects against mechanical overloading-induced cartilage clock disruption and osteoarthritis progression. Journal of Orthopaedic Translation. 53. 112–125.
2.
Ni, Bowei, et al.. (2023). Tizoxanide as a novel theraputic candidate for osteoarthritis. Heliyon. 9(9). e19472–e19472. 1 indexed citations
3.
Wang, Ying-Guang, Shanxi Wang, Xiaojun Yu, et al.. (2023). A comprehensive analysis of single-cell RNA transcriptome reveals unique SPP1+ chondrocytes in human osteoarthritis. Computers in Biology and Medicine. 160. 106926–106926. 26 indexed citations
4.
Ni, Bowei, Rui Zhang, Xiangyu Chu, et al.. (2021). MCC950, the NLRP3 Inhibitor, Protects against Cartilage Degradation in a Mouse Model of Osteoarthritis. Oxidative Medicine and Cellular Longevity. 2021(1). 4139048–4139048. 43 indexed citations
5.
Yan, Jiyuan, Bowei Ni, Gaohong Sheng, et al.. (2021). Rhoifolin Ameliorates Osteoarthritis via Regulating Autophagy. Frontiers in Pharmacology. 12. 661072–661072. 18 indexed citations
6.
Yan, Jiyuan, Yingchi Zhang, Gaohong Sheng, et al.. (2021). Selonsertib Alleviates the Progression of Rat Osteoarthritis: An in vitro and in vivo Study. Frontiers in Pharmacology. 12. 687033–687033. 7 indexed citations
7.
Huang, Xiaojian, et al.. (2021). Selective STAT3 Inhibitor Alantolactone Ameliorates Osteoarthritis via Regulating Chondrocyte Autophagy and Cartilage Homeostasis. Frontiers in Pharmacology. 12. 730312–730312. 28 indexed citations
8.
Huang, Xiaojian, et al.. (2021). Chondroprotective and antiarthritic effects of galangin in osteoarthritis: An in vitro and in vivo study. European Journal of Pharmacology. 906. 174232–174232. 13 indexed citations
9.
10.
Yang, Xi, Xiaojian Huang, Xiangyu Chu, et al.. (2020). Protective effects of Erdosteine on interleukin-1β-stimulated inflammation via inhibiting the activation of MAPK, NF-κB, and Wnt/β-catenin signaling pathways in rat osteoarthritis. European Journal of Pharmacology. 873. 172925–172925. 15 indexed citations
11.
Chu, Xiangyu, Tao Yu, Xiaojian Huang, et al.. (2020). Tomatidine suppresses inflammation in primary articular chondrocytes and attenuates cartilage degradation in osteoarthritic rats. Aging. 12(13). 12799–12811. 17 indexed citations
12.
Huang, Xiaojian, Xi Yang, Bowei Ni, et al.. (2019). p-Coumaric Acid Attenuates IL-1β-Induced Inflammatory Responses and Cellular Senescence in Rat Chondrocytes. Inflammation. 43(2). 619–628. 42 indexed citations
13.
Huang, Xiaojian, Bowei Ni, Zekai Mao, et al.. (2019). NOV/CCN3 induces cartilage protection by inhibiting PI3K/AKT/mTOR pathway. Journal of Cellular and Molecular Medicine. 23(11). 7525–7534. 40 indexed citations
14.
Huang, Xiaojian, Xi Yang, Zekai Mao, et al.. (2019). Vanillic acid attenuates cartilage degeneration by regulating the MAPK and PI3K/AKT/NF-κB pathways. European Journal of Pharmacology. 859. 172481–172481. 58 indexed citations
15.
Huang, Xiaojian, Bowei Ni, Xi Yang, et al.. (2019). Protease-activated receptor 2 (PAR-2) antagonist AZ3451 as a novel therapeutic agent for osteoarthritis. Aging. 11(24). 12532–12545. 39 indexed citations
16.
Zhang, Yuemei, Lian Deng, Zekun Jiang, et al.. (2017). Retrospective investigation and analysis of sleep disorders on occurrence of polycystic ovary syndrome. Biomedical Research-tokyo. 28(2). 583–587. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Songjiang Yin Breakdown of academic impact, for papers by Zekai Mao Breakdown of academic impact, for papers by Pratap Devarapalli Breakdown of academic impact, for papers by Dengying Wu Breakdown of academic impact, for papers by Jun Pan Breakdown of academic impact, for papers by Yumei Ding Breakdown of academic impact, for papers by Ju‐Ryoung Kim Breakdown of academic impact, for papers by Xiangyi Chen
Rankless by CCL
2026